Condensed Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 9,702,755	$ 4,739,426
Accounts receivable, net of allowance for credit losses of $0	1,451,904	673,071
Prepaid expenses	704,215	885,040
Inventories	588,776	481,840
Other current assets	6,312	47,532
Total current assets	12,453,962	6,826,909
Deferred offering costs		241,637
Total assets	12,453,962	7,068,546
Current Liabilities:
Accounts payable and accrued expenses	1,953,959	1,711,778
Accrued compensation	265,881	1,324,010
Note payable	5,000,000	5,000,000
Accrued interest payable	1,736,953	1,612,295
Total current liabilities	8,956,793	9,648,083
Total liabilities	8,956,793	9,648,083
Commitments and contingencies (Note 3)
Stockholders' equity (deficit):
Preferred stock, $0.0001 par value; authorized shares - 5,000,000 as of March 31, 2024 and December 31, 2023; issued and outstanding shares - zero as of March 31, 2024 and December 31, 2023	0	0
Common stock, $0.0001 par value; authorized shares - 50,000,000 as of March 31, 2024 and December 31, 2023; issued and outstanding shares - 8,597,405 and 3,343,070 as of March 31, 2024 and December 31, 2023, respectively	859	334
Additional paid-in capital	128,515,568	120,859,567
Accumulated deficit	(125,019,258)	(123,439,438)
Total stockholders' equity (deficit)	3,497,169	(2,579,537)
Total liabilities and stockholders' equity (deficit)	$ 12,453,962	$ 7,068,546